Gildess FE 1.5/30 (norethindrone acetate, 1.5 mg and ethinyl estradiol tablets, 0.03 mg, USP and ...

FDA Drug Recall #D-0122-2017 — Class III — September 27, 2016

Recall Summary

Recall Number D-0122-2017
Classification Class III — Low risk
Date Initiated September 27, 2016
Status Completed
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Par Pharmaceutical, Inc.
Location Chestnut Ridge, NY
Product Type Drugs
Quantity 278,406 tablets

Product Description

Gildess FE 1.5/30 (norethindrone acetate, 1.5 mg and ethinyl estradiol tablets, 0.03 mg, USP and ferrous fumarate tablets, USP 75 mg), 6 blisters (28 count), NDC 0603-7608-17, Rx only, Manufactured in Canada By: Patheon, Inc., Ontario, Canada L5N 7K9, Manufactured for QUALITEST PHARMACEUTICALS, USA, Huntsville, AL 35811

Reason for Recall

Subpotent Drug; Ethinyl Estradiol

Distribution Pattern

Nationwide and Puerto Rico

Lot / Code Information

Lot Numbers: 4169952, 4169953, 4169954, 4185520, 4187127, 4190281, 4228446, 4258626, 4258627, 4279364, 4279365, 4279366, 4279369, 4359310, 4365283, 4365285, 4365286, 4365287, 4365288, 4379816, 4379817, 4479997, 4501273, 4501274, 4501275, 4563362, 4563363, 4563364, 4614359, 4614360, 4614361

Other Recalls from Par Pharmaceutical, Inc.

Recall # Classification Product Date
D-1293-2019 Class I Mycophenolate Mofetil for Injection, USP 500 m... Apr 30, 2019
D-1185-2018 Class III Pramipexole dihydrochloride extended release ta... Sep 6, 2018
D-0154-2017 Class II Travoprost Ophthalmic Solution USP, 0.004%, a) ... Oct 5, 2016
D-0121-2017 Class III Gildess FE 1/20 (norethindrone acetate, 1 mg an... Sep 27, 2016
D-0123-2017 Class III Gildess 24 FE 1.5/30 (norethindrone acetate, 1 ... Sep 27, 2016

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.